Sandy Spring Bank’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Sandy Spring Bank’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-300	Closed	-$4.43K	–	1356
2024 Q1	$4.43K	Hold	300	–	–	﹤0.01%	976
2023 Q4	$4.02K	Hold	300	–	–	﹤0.01%	939
2023 Q3	$3.7K	Hold	300	–	–	﹤0.01%	966
2023 Q2	$3.69K	Hold	300	–	–	﹤0.01%	1008
2023 Q1	$3.69K	Hold	300	–	–	﹤0.01%	971
2022 Q4	$3.44K	Hold	300	–	–	﹤0.01%	974
2022 Q3	$1K	Hold	300	–	–	﹤0.01%	1123
2022 Q2	$2K	Hold	300	–	–	﹤0.01%	1070
2022 Q1	$2K	Hold	300	–	–	﹤0.01%	1079
2021 Q4	$1K	Hold	300	–	–	﹤0.01%	1210
2021 Q3	$1K	Hold	300	–	–	﹤0.01%	1126
2021 Q2	$2K	Hold	300	–	–	﹤0.01%	1098
2021 Q1	$2K	Hold	300	–	–	﹤0.01%	962
2020 Q4	$2K	Hold	300	–	–	﹤0.01%	915
2020 Q3	$1K	Hold	300	–	–	﹤0.01%	920
2020 Q2	$1K	Hold	300	–	–	﹤0.01%	894
2020 Q1	$1K	Hold	300	–	–	﹤0.01%	892
2019 Q4	$1K	Hold	300	–	–	﹤0.01%	830
2019 Q3	$1K	Sell	300 -81	-21%	-$405	﹤0.01%	837
2019 Q2	$2K	Hold	381	–	–	﹤0.01%	815
2019 Q1	$2K	Hold	381	–	–	﹤0.01%	763
2018 Q4	$1K	Hold	381	–	–	﹤0.01%	766
2018 Q3	$2K	Hold	381	–	–	﹤0.01%	756
2018 Q2	$1K	Hold	381	–	–	﹤0.01%	756
2018 Q1	$2K	Hold	381	–	–	﹤0.01%	808
2017 Q4	$3K	Hold	381	–	–	﹤0.01%	794
2017 Q3	$4K	Buy	381 +254	+200%	+$2.67K	﹤0.01%	762
2017 Q2	$1K	Hold	127	–	–	﹤0.01%	828
2017 Q1	$3K	Hold	127	–	–	﹤0.01%	801
2016 Q4	$4K	Hold	127	–	–	﹤0.01%	772
2016 Q3	$6K	Hold	127	–	–	﹤0.01%	726
2016 Q2	$5K	Hold	127	–	–	﹤0.01%	784
2016 Q1	$8K	Hold	127	–	–	﹤0.01%	736
2015 Q4	$8K	Buy	+127	New	+$8.94K	﹤0.01%	709
2015 Q3	–	Sell	-102	Closed	-$10K	–	1027
2015 Q2	$10K	Buy	+102	New	+$9.71K	﹤0.01%	706

Other funds holding MACK

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Sandy Spring Bank's MACK Position: Q2 2024 in Review

Sandy Spring Bank sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2024, closing a stake of 300 shares — an estimated $4.43K sold.

Sandy Spring Bank first reported a position in MACK in Q2 2015 and held it in 35 quarters. The position peaked at $10K in Q2 2015. 12 funds tracked by Wall St. Rank hold MACK as of Q2 2024.

Sandy Spring Bank reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
Sandy Spring Bank sold 300 Merrimack Pharmaceuticals, Inc. shares in Q2 2024, an estimated $4.43K.
Sandy Spring Bank first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2015 and held it in 35 quarters.
Sandy Spring Bank's Merrimack Pharmaceuticals, Inc. position peaked at $10K in Q2 2015.
12 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2024.

Based on Sandy Spring Bank's 13F filing for Q2 2024, filed 6 Aug 2024.